Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Viruses|January 22, 2015
Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454Seyed Mohammad Jazaeri Farsani, Bas B Oude Munnink, Marta Canuti, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 29, 2015
Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary careJolien Teepe, Berna D L Broekhuizen, Margareta Ieven, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 13, 2022
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021Patrick M Meyer Sauteur, Michael L Beeton, Søren A Uldum, et al.
Frontiers in Microbiology|July 30, 2014
Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirusMarta Canuti, Martin Deijs, Seyed M Jazaeri Farsani, et al.
JMIR Medical Informatics|March 8, 2025
Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE ProjectSalma Malik, Zoi Pana Dorothea, Christos D Argyropoulos, et al.
The European Journal of General Practice|October 23, 2023
Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemicAlike W van der Velden, Milensu Shanyinde, Emily Bongard, et al.
Nature Medicine|September 15, 2020
Seasonal coronavirus protective immunity is short-lastingArthur W D Edridge, Joanna Kaczorowska, Alexis C R Hoste, et al.
Plos One|November 14, 2013
Autologous antibody capture to enrich immunogenic viruses for viral discoveryBas B Oude Munnink, Seyed Mohammad Jazaeri Farsani, Martin Deijs, et al.
Vaccine|June 27, 2026
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)Cristina Prat-Aymerich, Lusine Yeghiazaryan, Rishi Delan Pathirana, et al.
Microbiology Spectrum|September 26, 2022
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 OutpatientsIlke De Boeck, Eline Cauwenberghs, Irina Spacova, et al.
Pageof 4